Solid Biosciences Book Value Per Share Growth & History (SLDB)
Solid Biosciences's book value per share was $2.28 for fiscal 2025.
View full Solid Biosciences company overviewSolid Biosciences annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.28 | -$1.11 | −32.79% |
| 2024 | 2024-12-31 | $3.39 | -$2.81 | −45.34% |
| 2023 | 2023-12-31 | $6.20 | -$4.62 | −42.68% |
| 2022 | 2022-12-31 | $10.82 | -$17.48 | −61.76% |
| 2021 | 2021-12-31 | $28.30 | -$1,527.59 | −98.18% |
| 2020 | 2020-12-31 | $1,555.89 | -$184.75 | −10.61% |
| 2019 | 2019-12-31 | $1,740.64 | -$1,792.36 | −50.73% |
| 2018 | 2018-12-31 | $3,533.00 | $3,537.34 | — |
| 2017 | 2017-12-31 | -$4.34 | $22,295.92 | — |
| 2016 | 2016-12-31 | -$22,300.26 | — | — |
Solid Biosciences quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.56 | $0.23 | +6.91% |
| Q1 2026 | 2026-03-31 | $3.80 | $0.00 | +0.07% |
| Q4 2025 | 2025-12-31 | $2.28 | -$1.11 | −32.79% |
| Q3 2025 | 2025-09-30 | $2.80 | -$1.49 | −34.77% |
| Q2 2025 | 2025-06-30 | $3.33 | -$1.68 | −33.60% |
| Q1 2025 | 2025-03-31 | $3.80 | -$1.77 | −31.78% |
| Q4 2024 | 2024-12-31 | $3.39 | -$2.81 | −45.34% |
| Q3 2024 | 2024-09-30 | $4.29 | -$2.91 | −40.38% |
| Q2 2024 | 2024-06-30 | $5.01 | -$3.16 | −38.63% |
| Q1 2024 | 2024-03-31 | $5.57 | -$3.82 | −40.68% |
| Q4 2023 | 2023-12-31 | $6.20 | -$4.62 | −42.68% |
| Q3 2023 | 2023-09-30 | $7.20 | -$11.82 | −62.17% |
| Q2 2023 | 2023-06-30 | $8.17 | -$1,427.99 | −99.43% |
| Q1 2023 | 2023-03-31 | $9.39 | -$1,635.48 | −99.43% |
| Q4 2022 | 2022-12-31 | $10.82 | -$17.48 | −61.76% |
| Q3 2022 | 2022-09-30 | $19.02 | -$2,006.11 | −99.06% |
| Q2 2022 | 2022-06-30 | $1,436.16 | -$721.11 | −33.43% |
| Q1 2022 | 2022-03-31 | $1,644.87 | -$649.11 | −28.30% |
| Q4 2021 | 2021-12-31 | $28.30 | -$1,527.59 | −98.18% |
| Q3 2021 | 2021-09-30 | $2,025.13 | $1,543.72 | +320.66% |
| Q2 2021 | 2021-06-30 | $2,157.27 | $1,271.96 | +143.68% |
| Q1 2021 | 2021-03-31 | $2,293.98 | $1,068.56 | +87.20% |
| Q4 2020 | 2020-12-31 | $1,555.89 | -$184.75 | −10.61% |
| Q3 2020 | 2020-09-30 | $481.41 | -$1,877.88 | −79.59% |
| Q2 2020 | 2020-06-30 | $885.30 | -$1,275.64 | −59.03% |
| Q1 2020 | 2020-03-31 | $1,225.42 | -$1,573.20 | −56.21% |
| Q4 2019 | 2019-12-31 | $1,740.64 | -$1,792.36 | −50.73% |
| Q3 2019 | 2019-09-30 | $2,359.29 | -$1,735.06 | −42.38% |
| Q2 2019 | 2019-06-30 | $2,160.94 | -$2,417.78 | −52.80% |
| Q1 2019 | 2019-03-31 | $2,798.62 | -$2,245.51 | −44.52% |
| Q4 2018 | 2018-12-31 | $3,533.00 | — | — |
| Q3 2018 | 2018-09-30 | $4,094.35 | — | — |
| Q2 2018 | 2018-06-30 | $4,578.73 | — | — |
| Q1 2018 | 2018-03-31 | $5,044.13 | — | — |
Solid Biosciences book value per share trends
Over the last five fiscal years, Solid Biosciences's book value per share decreased from $1,555.89 to $2.28, a change of -$1,553.61. The latest reported quarter, Q2 2026, shows $3.56.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Solid Biosciences source filings ↗